Search Result "(PLA2)"
Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3656-3661
Author(s): Alexandros D. Tselepis, Manfredi Rizzo, Ioannis A. Goudevenos
The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Cardiovascular Disease
Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 2 Year: 2011 Page: 108-113
Author(s): Ignatios Ikonomidis, Christos A. Michalakeas, John Lekakis, John Parissis, Maria Anastasiou-Nana
An Update on Inhibitors of Human 14 kDa Type II s-PLA2 in Development
Journal: Current Pharmaceutical Design
Volume: 7 Issue: 3 Year: 2001 Page: 181-198
Author(s): Dane M. Springer
3D QSAR Study of Human PLA2 Inhibitors. A Modeling Approach to Select New and Specific Anti-Inflammatory Drugs
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5 Issue: 2 Year: 2006 Page: 175-187
Author(s): Marco Pintore, Enrico Mombelli, Christophe Wechman, Jacques R. Chretien
A Catalytically Inactive Lys49 PLA2 Isoform from Bothrops jararacussu venom that Stimulates Insulin Secretion in Pancreatic Beta Cells
Journal: Protein & Peptide Letters
Volume: 18 Issue: 1 Year: 2011 Page: 1133-1139
Author(s): Fabio H.R. Fagundes, Ricardo Aparicio, Marcelo L. dos Santos, Eduardo B.S. Diz Filho, Simone C.B. Oliveira, Daniela O. Toyama, Marcos H. Toyama
Chemistry and Biology of Anti-Inflammatory Marine Natural Products. Phospholipase A2 Inhibitors
Journal: Current Organic Chemistry
Volume: 9 Issue: 1 Year: 2005 Page: 1419-1427
Author(s): Luigi Gomez-Paloma, Maria C. Monti, Stefania Terracciano, Agostino Casapullo, Raffaele Riccio
Group IIA Secretory PLA2 Inhibition by Ursolic Acid: A Potent Anti-Inflammatory Molecule
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 8 Year: 2007 Page: 801-809
Author(s): A. Nataraj, C. D. Raghavendra Gowda, R. Rajesh, B. S. Vishwanath
Bee Venom PLA2 versus Snake Venom PLA2: Evaluation of Structuraland Functional Properties
Journal: Venoms and Toxins
Volume: 2 Issue: 1 Year: 2022 Page: 22-33
Author(s): Lara Bitar,Mohamad Rima,Jean-Marc Sabatier
Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 4 Year: 2011 Page: 236-246
Author(s): Mohamed S. Ahmed, Jing Zhan Ji, Qing H. Meng
Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2018 Page: 114-119
Author(s): Teuku Heriansyah,Nafisa Nafisatuzzamrudah,Fitria N. Aini,Muhammad Ridwan,Rozah F. Primardhika,Maya Wijayanti,Rachmad S. Bekti,Titin A. Wihastuti